Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Corradin

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
European Journal of Immunology|September 1, 1992
Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptideB Lethé, B van den Eynde, A van Pel, et al.
European Journal of Immunology|December 1, 1989
Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsP Panina-Bordignon, A Tan, A Termijtelen, et al.
Clinical and Experimental Immunology|November 20, 1998
An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cellsG Eberl, S Jiang, Z Yu, et al.
Pharmaceutical Research|August 4, 1998
Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additivesP Johansen, Y Men, R Audran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J miceM Astori, C von Garnier, A Kettner, et al.
International Immunology|November 1, 1993
MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motifG Eberl, A Sabbatini, C Servis, et al.
Clinical and Experimental Immunology|February 1, 1994
Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impairedC Barbey, J M Tiercy, N Fairweather, et al.
Nature|December 11, 1986
H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptideJ L Maryanski, P Pala, G Corradin, et al.
Molecular Immunology|July 1, 1987
Biochemical characterization of a T-lymphoma-specific 90,000 molecular weight disulfide linked dimeric glycoproteinA Spiazzi, G Corradin, R Nagasawa, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 10, 2002
In vivo kinetics of the immunoglobulin E response to allergen: bystander effect of coimmunization and relationship with anaphylaxisC Von Garnier, M Astori, A Kettner, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
European Journal of Immunology|September 1, 1992
Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptideB Lethé, B van den Eynde, A van Pel, et al.
European Journal of Immunology|December 1, 1989
Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cellsP Panina-Bordignon, A Tan, A Termijtelen, et al.
Clinical and Experimental Immunology|November 20, 1998
An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cellsG Eberl, S Jiang, Z Yu, et al.
Pharmaceutical Research|August 4, 1998
Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additivesP Johansen, Y Men, R Audran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J miceM Astori, C von Garnier, A Kettner, et al.
International Immunology|November 1, 1993
MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motifG Eberl, A Sabbatini, C Servis, et al.
Clinical and Experimental Immunology|February 1, 1994
Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impairedC Barbey, J M Tiercy, N Fairweather, et al.
Nature|December 11, 1986
H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptideJ L Maryanski, P Pala, G Corradin, et al.
Molecular Immunology|July 1, 1987
Biochemical characterization of a T-lymphoma-specific 90,000 molecular weight disulfide linked dimeric glycoproteinA Spiazzi, G Corradin, R Nagasawa, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 10, 2002
In vivo kinetics of the immunoglobulin E response to allergen: bystander effect of coimmunization and relationship with anaphylaxisC Von Garnier, M Astori, A Kettner, et al.
Pageof 17